How this ETF's holdings score on the six lenses, weighted by holding weight. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
No NSE price series mapped for this ETF — lens roll-up only.
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Pharma | 18.37% | 10 | 8 | 6 | 4 | 2 | 1/2 | +13.9% |
| DIVISLAB | Pharma | 8.17% | 10 | 8 | 1 | 6 | 1 | 1/2 | +8.1% |
| APOLLOHOSP | Healthcare | 8.11% | 10 | 5 | 7 | 2 | 2 | 0/2 | +14.5% |
| DRREDDY | Pharma | 7.66% | 7 | 2 | 5 | 1 | 7 | 0/2 | -0.3% |
| CIPLA | Pharma | 7.60% | 6 | 3 | 5 | 3 | 6 | 0/2 | +13.9% |
| MAXHEALTH | Healthcare | 6.92% | 7 | 9 | 5 | 4 | 3 | 0/2 | +12.2% |
| LUPIN | Pharma | 5.30% | 10 | 10 | 10 | 6 | 7 | 1/2 | +4.0% |
| LAURUSLABS | Pharma | 5.11% | 8 | 9 | 4 | 4 | 1 | 0/2 | +34.0% |
| FORTIS | Healthcare | 4.67% | 8 | 8 | 5 | 2 | 3 | 0/2 | +8.9% |
| TORNTPHARM | Pharma | 4.45% | 10 | 8 | 5 | 6 | 1 | 1/2 | +14.6% |
| AUROPHARMA | Pharma | 3.84% | 9 | 3 | 10 | 6 | 6 | 0/2 | +14.4% |
| GLENMARK | Pharma | 3.30% | 6 | 9 | 10 | 4 | 3 | 0/2 | +1.5% |
| ALKEM | Pharma | 3.10% | 9 | 8 | 8 | 10 | 6 | 1/2 | +0.5% |
| BIOCON | Pharma | 2.95% | 6 | 1 | 10 | 5 | 3 | 0/2 | +12.5% |
| ZYDUSLIFE | Pharma | 2.60% | 10 | 10 | 10 | 10 | 6 | 1/2 | +23.3% |
| MANKIND | Pharma | 2.59% | 10 | 8 | 9 | 5 | 2 | 0/2 | +18.5% |
| IPCALAB | Pharma | 2.04% | 10 | 6 | 1 | 8 | 4 | 1/2 | +18.3% |
| ABBOTINDIA | Pharma | 1.35% | 4 | 9 | — | 8 | 7 | 0/2 | +0.6% |
| PPLPHARMA | Pharma | 1.03% | 6 | 1 | 5 | 4 | 6 | 0/2 | +14.5% |
| SYNGENE | Healthcare | 0.81% | 2 | 3 | 6 | 9 | 7 | 0/2 | -0.6% |
Native from atlas_foundation — the lens journal looked through de_etf_holdings; identity from Morningstar (de_mf_master). ← Back to ETFs